Zekarias, Alem https://orcid.org/0000-0003-0297-8881
Meldau, Eva-Lisa https://orcid.org/0000-0003-0268-7769
Bista, Shachi https://orcid.org/0000-0001-8319-4936
Félix China, Joana https://orcid.org/0009-0009-2718-7518
Sandberg, Lovisa https://orcid.org/0000-0001-6982-5244
Article History
Accepted: 10 February 2025
First Online: 15 March 2025
Declarations
:
: There was no specific funding for this study.
: The authors declare that they have no competing interests.
: Not applicable. The data in VigiBase are de-identified and not considered personal data.
: Not applicable.
: Not applicable.
: The data that support the findings of this study are not publicly available. Access to the data is restricted on the basis of the conditions for access within the WHO Programme for International Drug Monitoring. Subject to these conditions, data are available from the authors on reasonable request. Contact Alem.Zekarias@who-umc.org.
: The code used for this study is not publicly available but may be made available upon reasonable request. Contact Eva-Lisa.Meldau@who-umc.org.
: All authors (A.Z., E.L.M., S.B., J.F.C. and L.S.) designed and conceptualised the study, interpreted the data, drafted the manuscript and revised the manuscript. Additionally, S.B. and E.L.M. implemented the methods. J.F.C. defined the queries used for evaluation. A.Z. annotated the evaluation dataset. All authors have read and approved the final version of the manuscript.